As filed with the Securities and Exchange Commission on October 1, 2015

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF l934

 

 

Wright Medical Group N.V.

(Exact name of Registrant as specified in its charter)

 

 

 

The Netherlands   98-0509600
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

 

Prins Bernhardplein 200

1097 JB Amsterdam, The Netherlands

  None
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Contingent Value Rights   The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.   x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.   ¨

Securities Act registration statement file number to which this form relates: 333-185601

Securities to be registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

 

 

 


As filed with the Securities and Exchange Commission on October 1, 2015

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

On October 1, 2015, Tornier N.V. (“ Tornier ”) and Wright Medical Group, Inc. (“ Wright ”) completed their previously announced merger pursuant to the Agreement and Plan of Merger, dated as of October 27, 2014 (the “ Merger Agreement ”), by and among the Tornier, Wright, Trooper Holdings Inc. and Trooper Merger Sub Inc. The Merger Agreement provided for the merger of Trooper Merger Sub Inc. with and into Wright, with Wright continuing as the surviving corporation and a wholly-owed indirect subsidiary of Tornier (the “ Merger ”). Following the Merger, Tornier changed its name to Wright Medical Group N.V. (the “ Combined Company ”).

Upon completion of the Merger, the Combined Company assumed the Contingent Value Rights issued by Wright pursuant to a Contingent Value Rights Agreement, dated as of March 1, 2013, by and between Wright and American Stock Transfer & Trust Company, LLC, as trustee (the “ Trustee ”). The Contingent Value Rights were assumed pursuant to an Assignment and Assumption Agreement, dated as of October 1, 2015, by and between Wright, the Tornier and the Trustee. The Assignment and Assumption Agreement is filed as Exhibit 4.2 hereto and incorporated by reference herein.

The description of the Contingent Value Rights included under the caption “Description of the CVRs” in the prospectus filed by Wright, which constitutes a part of the Registration Statement on Form S-4 (Registration No. 333-185601), filed by Wright with the Securities and Exchange Commission on December 21, 2012 pursuant to the Securities Act of 1933, as amended, is hereby incorporated by reference.

 

Item 2. Exhibits.

 

  4.1 Contingent Value Rights Agreement, dated as of March 1, 2013, by and between Wright Medical Group, Inc. and American Stock Transfer & Trust Company, LLC, as trustee, which includes the Form of CVR Certificate as Annex A (incorporated by reference to Wright Medical Group Inc.’s Registration Statement on Form 8-A, Registration No. 001-35823, filed by Wright Medical Group, Inc. on March 1, 2013).

 

  4.2 Assignment and Assumption Agreement, dated as of October 1, 2015, by and between Wright Medical Group N.V., Wright Medical Group, Inc. and American Stock Transfer & Trust Company, LLC, as trustee (filed herewith).


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Dated: October 1, 2015   WRIGHT MEDICAL GROUP N.V.
  (Registrant)
  By:  

/s/ Robert J. Palmisano

  Name:   Robert J. Palmisano
  Title:   President and Chief Executive Officer


EXHIBIT INDEX

 

Exhibit
No.

  

Description

4.1    Contingent Value Rights Agreement, dated as of March 1, 2013, by and between Wright Medical Group, Inc. and American Stock Transfer & Trust Company, LLC, as trustee, which includes the Form of CVR Certificate as Annex A (incorporated by reference to Wright Medical Group Inc.’s Registration Statement on Form 8-A, Registration No. 001-35823, filed by Wright Medical Group Inc. on March 1, 2013).
4.2    Assignment and Assumption Agreement, dated as of October 1, 2015, by and between Tornier N.V., Wright Medical Group, Inc. and American Stock Transfer & Trust Company, LLC, as trustee (filed herewith).

Exhibit 4.2

ASSIGNMENT AND ASSUMPTION AGREEMENT

This Assignment and Assumption Agreement (this “ Agreement ”) is made and entered into as of October 1, 2015, by and between Wright Medical Group, Inc., a Delaware corporation (“ Assignor ” or “ Wright ”), Tornier N.V., a Dutch public limited company ( naamloze vennootschap ) (“ Assignee ”) and American Stock Transfer & Trust Company, LLC, a New York limited liability company, as trustee (the “ Trustee ”). All capitalized terms used but not defined in this Agreement have the meanings given to them in the Merger Agreement referred to below.

WHEREAS, Assignor and the Trustee have entered into a Contingent Value Rights Agreement, dated March 1, 2013 (the “ CVR Agreement ”);

WHEREAS, Assignor, Assignee, Trooper Holdings Inc., a Delaware corporation and a direct wholly-owned subsidiary of Tornier, and Trooper Merger Sub Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Tornier, are parties to that certain Agreement and Plan of Merger, dated as of October 27, 2014 (the “ Merger Agreement ”), which provides that Trooper Merger Sub Inc. will merge with and into Wright, with Wright continuing as the surviving corporation and wholly-owed indirect subsidiary of Tornier (the “ Merger ”). In connection with the Merger, as of the Effective Time (as defined in the Merger Agreement), Tornier will be renamed Wright Medical Group, N.V. and organized under the laws of the Netherlands;

WHEREAS, in connection with the Merger, Assignor shall assign all of its rights, duties, obligations, liabilities and interests in, to and under the CVR Agreement to Assignee, and the Assignee shall assume all such rights, duties, obligations, liabilities and interests of the Assignor in, to and under the CVR Agreement, and Assignor and Assignee desire to execute and deliver this agreement as evidence of such assignment.

NOW, THEREFORE, in consideration of the mutual promises, covenants and agreements set forth in the Merger Agreement and herein, and for good and valuable consideration described in the Merger Agreement, the parties hereby agree as follows:

1. Assignment . Effective as of the Effective Time, Assignor hereby assigns to Assignee, and Assignee hereby accepts the assignment of, all of the Assignors’ rights, duties, obligations, liabilities, and interests in, to and under the CVR Agreement.

2. Assumption of Liabilities . Effective as of the Effective Time, Assignee hereby assumes and agrees to satisfy or perform, when due, any and all duties and obligations of the Assignor under the CVR Agreement with the same force and effect as if the Assignee had been originally named therein.

3. Successors and Assigns . This Agreement shall be binding upon and shall inure to the benefit of the respective parties hereto and their respective successors and assigns.

4. The undersigned parties hereby agree and acknowledge that additional rights, duties and obligations of the parties to the Merger Agreement are expressly provided for in the Merger Agreement, and that the execution and delivery of this Agreement shall not expand,


impair or diminish any of the rights or obligations of any of the parties to the Merger Agreement, as set forth therein. The undersigned parties acknowledge and agree that the representations, warranties, covenants, agreements and indemnities contained in the Merger Agreement shall not be superseded hereby but shall remain in full force and effect to the full extent provided therein. In the event of any conflict or inconsistency between the terms of the Merger Agreement and the terms hereof, the terms of the Merger Agreement shall govern.

5. Governing Law . The interpretation, construction and enforcement of this Agreement, and all matters relating to it, will be governed by the laws of the State of New York, without giving effect to any choice or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction.

6. Consent . The execution and delivery of this Agreement by the Assignor and the Trustee shall serve as written consent of both parties to amend the CVR agreement to allow Assignee to succeed Assignor under the CVR Agreement and assume all of the covenants of Assignor included therein.

7. No Further Amendment to CVR Agreement . Except as specifically modified hereby, all of the terms and conditions of the CVR Agreement shall remain unchanged and in full force and effect. No reference to this Agreement need be made in the CVR Agreement and effective as of the date hereof, any reference to the CVR Agreement shall be deemed to be a reference to the CVR Agreement as modified hereby.

8. Amendment . This Agreement may not be changed, modified, discharged or terminated orally or in any manner other than by an agreement in writing signed by the Trustee and the Assignee or their respective successors and assigns specifically identifying such writing as an amendment to this Agreement.

9. Counterparts . This Agreement may be executed in any number of counterparts, each of which will be an original and all of which taken together will constitute one and the same instrument.

[Signature Page Follows]


IN WITNESS WHEREOF, each of the undersigned has executed this Assignment and Assumption Agreement as an agreement under seal as of the date first written above.

 

ASSIGNOR :
WRIGHT MEDICAL GROUP, INC.
By:  

/s/ Lance A. Berry

Name:   Lance A. Berry
Title:   Senior Vice President and Chief Financial Officer
Date:   October 1, 2015

[Signature Page | Assignment and Assumption Agreement]


IN WITNESS WHEREOF, each of the undersigned has executed this Assignment and Assumption Agreement as an agreement under seal as of the date first written above.

 

ASSIGNEE :
TORNIER N.V.
By:  

/s/ Kevin M. Klemz

Name:   Kevin M. Klemz
Title:   Senior Vice President, Chief Legal Officer and Secretary
Date:   October 1, 2015

[Signature Page | Assignment and Assumption Agreement]


IN WITNESS WHEREOF, each of the undersigned has executed this Assignment and Assumption Agreement as an agreement under seal as of the date first written above.

 

TRUSTEE :
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
By:  

/s/ Jennifer Donovan

Name:   Jennifer Donovan
Title:   Senior Vice President
Date:   October 1, 2015

[Signature Page | Assignment and Assumption Agreement]